Skip to main
GLUE
GLUE logo

Monte Rosa Therapeutics (GLUE)


$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy GLUE Stock

About Monte Rosa Therapeutics (GLUE)

Monte Rosa Therapeutics, Inc. operates as a biotechnology company, which engages in the developing of precision medicines. The company was founded on November 21, 2019 and is headquartered in Boston, MA.
Market cap$1.04B
Yesterday's volume960.15K
Revenue (TTM)$181.54M
Avg. daily volume1.48M
EBITDA (TTM)$16.84M
Open$15.72
Price / earnings ratio52.46x
Yesterday's range$15.47 - $16.35
Debt / equity16.34x
52 week range$3.5 - $16.66
5 year debt / equity-16.3x
Beta (LTM)1.13x
Interest coverage
Dividend & yield$0.00 (0.00%)
Current ratio6.54x
Ex-dividend date
Next earningsMar 19, 2026
Dividend payable date

GLUE Stock Rating

What analysts recommend for GLUE stock, on a scale from 1(buy) to 5(sell).
Buy
Strong Buy 0%
Buy 67%
Hold 33%
Sell 0%
Strong Sell 0%

Frequently Asked Questions (FAQ)

As of Nov 25, 2025, the market cap for GLUE stock is $1.05B

The current P/E ratio for GLUE stock is 52.46

The 52-week high for GLUE stock is $16.66. The current GLUE stock price $undefined is 100.00% below its 52-week high

The 52-week low for GLUE stock is $3.50. The current GLUE stock price $undefined has increased 100.00% from its 52-week low

No, the GLUE stock does not pay dividends to its shareholders

The target price for GLUE stock is $16.33 based on the average of what a group of analyst think GLUE stock could be worth at a future date. This is not a prediction by Public.com

How to buy GLUE stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in GLUE stock

    Navigate to the Explore page. Then, type GLUE into the search bar. When you see GLUE stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased GLUE stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Monte Rosa Therapeutics Stock Earnings

The value each GLUE share was expected to gain vs. the value that each GLUE share actually gained.

GLUE (GLUE) reported Q3 2025 earnings per share (EPS) of -$0.33, beating estimates of -$0.37 by 10.81%. In the same quarter last year, GLUE's earnings per share (EPS) was -$0.29. GLUE is expected to release next earnings on 03/19/2026, with an earnings per share (EPS) estimate of -$0.38.

Buy GLUE Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.